SCHEMBL24246992

SCHEMBL24246992

CC(C)c1ccc(C2(N3CCN(C)CC3)CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
OPRM1 P35372 4/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
KCNH2 Q12809 2/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
CYP2B6 P20813 1/20 0.36
PRCP P42785 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
MC4R P32245 1/20 0.36
OPRD1 P41143 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26033099 0.85 GRIN1 (0.42) GRIN1GRIN2AGRIN2BOPRM1SLC6A2
SCHEMBL19869969 0.79 ALDH1A1 (0.44) GRIN1GRIN2AGRIN2BOPRM1SLC6A2
SCHEMBL10169480 0.75 OPRD1 (0.47) OPRM1HTR2AHTR2CSLC6A3OPRD1
SCHEMBL12925944 0.74 OPRM1 (0.49) GRIN1GRIN2AGRIN2BOPRM1KCNH2
SCHEMBL14279640 0.73 SLC6A4 (0.56) GRIN1GRIN2AGRIN2BOPRM1SLC6A2
SCHEMBL27598815 0.71 CYP2D6 (0.47) GRIN1GRIN2AGRIN2BOPRM1SLC6A2
SCHEMBL29964855 0.70 LPL (0.41) GRIN1GRIN2AGRIN2B
SCHEMBL20899292 0.69 GRIN1 (0.47) GRIN1GRIN2AGRIN2BOPRM1SLC6A2
SCHEMBL4120887 0.69 SLC6A9 (0.39) GRIN1GRIN2AGRIN2BOPRM1HTR2A
SCHEMBL101926 0.68 ALDH1A1 (0.64) SIGMAR1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11247990-B1 Bicyclic fused pyridine compounds as inhibitors of TAM kinases ARRAY BIOPHARMA INC (US) 2022-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11247990-B1 Bicyclic fused pyridine compounds as inhibitors of TAM kinases MAP3K1, MAP3K3, MAP3K2 GRIN1 1120/4885GRIN2A 1844/4885GRIN2B 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.